NovaBridge Biosciences Impairment Charge on Reclassified Assets
NovaBridge Biosciences (NBP) reported Impairment Charge on Reclassified Assets of $624.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentChargeOnReclassifiedAssets · last filed 2025-04-03
| Period end | Impairment Charge on Reclassified Assets 12 month |
|---|---|
| 2024-12-31 | $624.00K 20-F · filed 2025-04-03 |